peptic%20ulcer%20disease
PEPTIC ULCER DISEASE
Peptic ulcer disease is the presence of ulceration in the stomach and proximal duodenum commonly and in the lower esophagus, distal duodenum or jejunum infrequently. It is characterized by mucosal damage secondary to pepsin and gastric acid secretion.
It is the principal cause of upper gastrointestinal hemorrhage.
Appropriate therapy depends on the cause of peptic ulcer disease.

Surgical Intervention

  • Recommended in patients with more emergent complications (ie hemorrhage, perforation, gastric outlet obstruction), refractory disease and intractability, or rare causes of ulcer disease (eg gastrinoma, Zollinger-Ellison syndrome)
    • The most common indication for surgery is bleeding
    • Peritonitis is a surgical emergency that needs patient resuscitation, laparotomy and peritoneal toilet, or omental patch placement
  • Indications for elective peptic ulcer surgery include resection of ulcers suspected to be malignant, failure to heal despite maximal medical therapy, intolerance or noncompliance with medical regimen, and relapse while on maximal medical therapy
  • Options for duodenal ulcer may include truncal vagotomy, selective vagotomy, highly selective vagotomy, partial gastrectomy
  • Options for gastric ulcer may include partial gastrectomy with gastroduodenal or gastrojejunal anastomosis
  • Options to relieve chronic obstruction may include vagotomy and pyroplasty, antrectomy, or gastroenterostomy
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 May 2014

New drug applications approved by US FDA as of 15-30 May which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

28 Apr 2017
Silymarin does not appear to be significantly better than placebo in reducing disease activity by 30 percent or more in patients with nonalcoholic steatohepatitis (NASH), according to the results of a trial.
08 May 2017
Transabdominal bowel wall ultrasonography shows utility in monitoring disease activity in patients with active Crohn’s disease (CD), according to a study. The imaging technique is ideal for evaluating early transmural changes in disease activity, in response to medical treatment.